Nippon Kayaku Co., Ltd.

Nippon Kayaku Co., Ltd.

NPKYY
Nippon Kayaku Co., Ltd.US flagOther OTC
13.16
USD
- -
- -
1.95BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
883.22
893.22
905.42
918.19
969.58
997.08
1,014.69
1,015.17
1,093.9
1,183.07
1,216.73
1,362.48
626.91
Basic EPS, GAAP
- -
92.25
86.38
96.08
90.22
89.45
85.77
74.25
73.62
101.7
89.36
24.8
107.17
-11.94
Free Cash Flow per Basic Share
- -
65.31
25.12
26.49
95.52
41.45
61.98
62.74
63.73
80.94
42.06
43.53
-33.53
- -
Dividend per Share
- -
19.96
27.44
25.11
30.15
32.42
29.93
30.02
29.92
30.01
45.03
47.36
45.27
- -
Book Value per Share
- -
790.33
852.01
928.84
1,024.57
1,082.35
1,138.15
1,153.48
1,209.29
1,245.98
1,299.53
1,291.23
1,332.26
1,305.85
Tangible Book Value per Share
- -
965.31
1,087.31
1,102.08
1,174.27
1,253.45
1,302.66
1,197.33
1,296.51
1,413.73
1,481.88
1,609.02
1,618.86
1,569.98
Basic Weighted Avg Shares
181
181
181
180
173
173
173
173
171
169
168
166
163
166
Sales/Revenue/Turnover
- -
160,068
161,857
162,936
159,112
167,882
172,640
175,133
173,384
184,805
198,380
201,791
222,584
103,883
Operating Margin (%)
- -
15.05
13.78
13.33
12.35
13.47
11.55
9.98
8.76
11.39
10.84
3.64
9.17
2.47
Depreciation Expense
- -
10,435
10,743
11,238
11,343
11,673
11,969
12,584
13,473
14,099
14,240
14,402
14,077
- -
Net Income, GAAP
- -
16,718
15,653
17,291
15,635
15,488
14,851
12,815
12,574
17,181
14,984
4,113
17,508
-1,979
Effective Tax Rate (%)
- -
28.98
29.89
27.27
26.88
26.52
26.32
29.01
28.15
27.24
28.27
42
20.12
56.43
Profit Margin (%)
- -
10.44
9.67
10.61
9.83
9.23
8.6
7.32
7.25
9.3
7.55
2.04
7.87
-1.91
Working Capital
- -
100,572
102,367
111,430
112,281
115,068
120,546
114,302
119,361
130,083
146,988
143,331
151,188
132,519
LT Debt
- -
13,717
9,518
12,460
8,201
7,577
8,778
18,182
15,770
9,474
16,200
18,000
34,884
15,400
Total Equity
- -
177,933
199,678
200,490
205,863
220,616
229,042
210,018
228,272
246,424
255,024
270,547
268,518
264,200
Return on Invested Capital (%)
- -
16.85
7.45
7.19
6.45
7.24
6.09
5.16
4.51
5.95
5.68
1.47
5.29
- -
Return on Capital (%)
- -
17.66
8.17
8.62
7.46
7.12
6.46
5.76
5.63
7.55
6.43
1.7
6.95
1.69
Return on Common Equity (%)
- -
23.34
10.52
10.76
9.07
8.49
7.73
6.47
6.2
8.24
7
1.9
8.11
-0.91

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
13,450
- -
13,300
LT Borrowings
18,000
- -
15,400
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
166
- -
164
Market Capitalization
- -
- -
214,130

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
203,146
- -
195,196
Cash, Cash Equivalents & STI
66,177
- -
53,786
Accounts Receivable, Net
60,267
- -
59,840
Inventories
67,008
- -
71,886
Total Current Liabilities
59,815
- -
62,677
Payables & Accruals
- -
- -
- -
ST Debt
13,450
- -
13,300
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.12%
5.09%
-0.75%
Free Cash Flow
5%
-39.16%
-175.87%
Net Income, GAAP
25.72%
55.02%
325.67%
Sales/Revenue/Turnover
3.31%
4.99%
10.3%
Total Cash Common Dividend
5.12%
8.99%
-5.86%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
48,584
49,324
51,845
52,038
201,791
2025
- -
- -
- -
- -
222,584
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
16.05
- -
- -
- -
24.8
2025
- -
- -
- -
- -
107.17
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
47.36
2025
- -
- -
- -
- -
45.27
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Shigeyuki Kawamura
Full Time Employees
5,946
Sector
Basic Materials
Industry
Chemicals
Address
Meiji Yasuda Seimei Building Tokyo TY Japan 100-0005
IPO Date
Aug 3, 2012
Business
Nippon Kayaku Co., Ltd. Nippon Kayaku Co., Ltd. develops, manufactures and markets functional chemicals, pharmaceuticals, safety systems and agrochemicals across Japan, Asia, Europe and other international markets; founded in 1916 and headquartered in Tokyo, Japan. The Functional Chemicals segment provides epoxy resins and UV-curable resins for semiconductors and displays, photoresists and insulating materials for microelectromechanical systems, inkjet colorants, textile and paper dyes, catalysts for acrylic acid production, polarizing films, liquid crystal components and x-ray analysis parts; the Pharmaceuticals segment offers anti-cancer agents including ROS1 inhibitors, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drug intermediates and diabetes markers like GlycoMark; the Safety Systems segment supplies airbag inflators for driver, passenger, side, curtain and knee applications, micro gas generators for seatbelt pretensioners and squibs; the Agrochemicals segment delivers insecticides, herbicides, soil fumigants and sanitary insecticides. In August 2025, the company executed a shareholders agreement with Formiica Pharmaceuticals Pte. Ltd. and CBC Co., Ltd. to establish a Singapore-based joint venture for in-licensing and sublicensing pharmaceuticals into Asia including Japan and Oceania, granting Nippon Kayaku preferential rights for Japanese development and sales; in November 2025, it launched IBTROZI Capsules 200mg, an oncology drug for ROS1 fusion-positive non-small cell lung cancer exclusively licensed from Nuvation Bio Inc., following national health insurance listing; additionally in November 2024, it initiated a share buyback of up to 6.5 million shares for 7.0 billion yen to boost capital efficiency.